Generic competition not a cure-all for high drug prices

Modern Healthcare: Bringing more generic drugs to market is a critical component of lowering drug prices, but it is not a panacea, according to a new report.

The U.S. Food and Drug Administration has looked to increase generic competition as the primary lever to stem sky high drug prices. While the agency has succeeded in doing so, there's a ceiling on the ultimate impact of that plan, researchers from PricewaterhouseCoopers said.

Read article